Insider Transactions in Q1 2022 at Caribou Biosciences, Inc. (CRBU)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2022
|
Ryan Fischesser VP of Finance and Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
2,274
+1.0%
|
$6,822
$3.4 P/Share
|
|
Mar 04
2022
|
Steven Kanner Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,720
+2.29%
|
$32,160
$3.4 P/Share
|
|
Feb 08
2022
|
Jason O'Byrne Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,336
+50.0%
|
$97,344
$4.11 P/Share
|
|
Jan 26
2022
|
Rachel E. Haurwitz President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.3%
|
$20,000
$2.96 P/Share
|
|
Jan 25
2022
|
Syed Ali Aamir Rizvi Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+48.0%
|
-
|
|
Jan 11
2022
|
Ryan Fischesser VP of Finance and Controller |
BUY
Open market or private purchase
|
Direct |
7,387
+3.22%
|
$22,161
$3.4 P/Share
|